Quality under pressure: Strengthening continuity amid geopolitical uncertainty Kalyani Sharma Jun 2, 2026 One of the most persistent risks facing Indian pharma manufacturers is the industry's heavy dependence on China for KSMs and…
Lupin receives EIR from U.S. FDA for Aurangabad facility EP News Bureau Nov 13, 2025 The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
USFDA classifies Hyderabad FDF Unit-I of Cohance Lifesciences as Official Action Indicated EP News Bureau Oct 27, 2025 Company initiates remediation measures; confirms limited revenue contribution from the facility and no material impact on…
Dr Reddy’s Labs gets US FDA clearance: Visakhapatnam facilities classified as VAI EP News Bureau Aug 12, 2024 USFDA concludes inspection of Dr Reddy's Visakhapatnam units with Voluntary Action Indicated status